These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 1371412

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia.
    Mempel K, Pietsch T, Menzel T, Zeidler C, Welte K.
    Blood; 1991 May 01; 77(9):1919-22. PubMed ID: 1708293
    [Abstract] [Full Text] [Related]

  • 3. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
    Ward AC, van Aesch YM, Gits J, Schelen AM, de Koning JP, van Leeuwen D, Freedman MH, Touw IP.
    J Exp Med; 1999 Aug 16; 190(4):497-507. PubMed ID: 10449521
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel mechanism of G-CSF refractoriness in patients with severe congenital neutropenia.
    Druhan LJ, Ai J, Massullo P, Kindwall-Keller T, Ranalli MA, Avalos BR.
    Blood; 2005 Jan 15; 105(2):584-91. PubMed ID: 15353486
    [Abstract] [Full Text] [Related]

  • 8. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
    Wright DG, Kenney RF, Oette DH, LaRussa VF, Boxer LA, Malech HL.
    Blood; 1994 Aug 15; 84(4):1257-67. PubMed ID: 7519479
    [Abstract] [Full Text] [Related]

  • 9. The protein tyrosine kinase JAK2 is activated in neutrophils from patients with severe congenital neutropenia.
    Rauprich P, Kasper B, Tidow N, Welte K.
    Blood; 1995 Dec 15; 86(12):4500-5. PubMed ID: 8541539
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.
    Shitara T, Yugami S, Ijima H, Sotomatu M, Kuroume T.
    Am J Hematol; 1994 Jan 15; 45(1):58-62. PubMed ID: 7504401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.
    McLemore ML, Poursine-Laurent J, Link DC.
    J Clin Invest; 1998 Aug 01; 102(3):483-92. PubMed ID: 9691084
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alkaline phosphatase activity in neutrophils from patients with severe congenital neutropenia (Kostmann's syndrome).
    Baranova K, Stanulla M, Zeidler C, Welte K.
    Int J Hematol; 1999 Dec 01; 70(4):236-40. PubMed ID: 10643149
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.